Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,666   0.10  Index Moved Up 0.01%
JNJ PFE NVS SNY Data Storage Electronics Small Value Alcohol 
United States GSPC USD ...  |  Investing Toolset


Processing
Collecting data for SNY

Sanofi quote and profile

 
 Companies |  Insiders  | Dashboard  
     
54.25
  
STOCK
0.41  Macroaxis: 0.76 Up   0.76%  
Year To Date
33.0355.77
Last 1 Month(s)
52.7555.64
Trading Day 
54.1954.67
May 21 2013 

Diversification Suggestion

Use Sanofi to enhance returns of your portfolios. The stock experiences moderate upward volatility
Analyze Sanofi Trend or Check current 30 days Sanofi correlation with market (S&P 500)
1 Month Beta 1.63  
Highest Price:  
Lowest Price:  
55.64  
52.75  
May 03 2013 
April 22 2013 
As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Sanofi will likely underperform.
Sanofi Large BetaSanofi Beta Legend
SNY United States NYSE
Sanofi
Healthcare
Drug Manufacturers - Major
Benchmark S&P 500
http://www.sanofi-aventis.com
Contact Number: 33 1 53 77 40 00
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation150.6 B
Shares Outstanding2.65 B
Number of Shares Shorted2.83 M
Revenue46.55 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen SNY SNY agains markets  0.76 % Macroaxis: 0.76 Moved Up  
 
 United States SP 500   0.01 % Macroaxis: 0.01 Moved Down  
 
 United States Russel   0.12 % Macroaxis: 0.12 Moved Down  
 
 United States NYSE   0.14 % Macroaxis: 0.14 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Sanofi Leadership

David Khougazian Head of the Office of the CEO, Member of the Global Leadership Team, MBA
David Meeker Executive Vice President and CEO of Genzyme, Member of the Global Leadership Team
Christopher Viehbacher CEO, Director and Member of Strategy Committee
Jean-Francois Dehecq Honorary Chairman and President of The Sanofi Espoir Foundation

Sanofi Price and Market Media

The median price of Sanofi for the period between Sun, Apr 21, 2013 and Tue, May 21, 2013 is 54.3 with a coefficient of variation of 1.48. The daily time series for the period is distributed with a sample standard deviation of 0.8, arithmetic mean of 54.15, and mean deviation of 0.67. The Stock received some media coverage during the period.
Sanofi         SP 500
Price Growth (%)
 
1
Novartis AG Sanofi SA Regeneron Pharmaceuticals ...04/25/2013Macroaxis: News
2
Stock Losers Cytokinetics Sanofi SA Golden Star Resources Lt...05/08/2013Macroaxis: News
3
VIVUS Inc. You39ve Got To Spend Money To Make Money05/10/2013Macroaxis: News

Sanofi Summary

Sanofi [SNY] is traded on New York Stock Exchange in USA. It is located in , Rue La BoParis, and employs 111,974 people. The company currently falls under 'Mega-Cap' category with total capitalization of 140.17 B. Sanofi runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 2.65 B outstanding shares of which 2.83 M shares are at this time shorted by investors with about 1.5 days to cover shorted positions.
Sanofi researches, develops, manufactures, and markets healthcare solutions worldwide. more
Past Market
Over 30
Days
3
Out Of
100
 
Chance of
Less
Than
15 %
 
Follow Sanofi with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Sanofi to your reader
 

Sanofi Research Report

Sanofi vs. Johnson

Correlation analysis and fundamentals comparison between Sanofi and Johnson Johnson

Sanofi Executives

Jerome Contamine CFO and Executive VP

Sanofi Directors

Claudie Haignere Independent Director, Ph.D
Uwe Bicker Independent Director, Ph.D
Thierry Desmarest Director, MBA
Lord Douro Independent Director
Robert Castaigne Director, Ph.D

Sanofi Fundamentals

Net Income vs Return On Equity
Cash Flow from Operations vs Beta
Net Income vs Earnings Per Share
Shares Outstanding vs Beta

Sanofi vs Competition

Sanofi vs. Johnson Johnson
Sanofi vs. Pfizer Inc
Sanofi vs. Novartis AG
Sanofi vs. Merck Co Inc
Sanofi vs. GlaxoSmithKline plc
Sanofi vs. BristolMyers Squibb Company
Sanofi vs. AstraZeneca PLC
Sanofi vs. Eli Lilly and Company
Sanofi vs. Impax Laboratories Inc

Sanofi May 21 2013 Opportunity Range

Downside Deviation2.03
Information Ratio(0.10)
Maximum Drawdown8.7
Value At Risk(2.65)
Potential Upside2.9

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium